In another study, to further illustrate the biological importance of this gene in CRC, Pucci and her group obtained gene expression data of 626 COAD/READ samples from the TCGA database and divided CRC patients based on B4GALNT2 expression into two different groups, including higher and lower expressers. The gene discussed is B4GALNT2; the disease is colorectal carcinoma.